Euclidean Capital LLC reported 10 holdings worth US$324M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Euclidean Capital LLC reported 10 holdings worth US$324M as of Sep 30, 2026. Largest: Vanguard FTSE All-World ex-US Index Fund, iShares MSCI India ETF and ORIC Pharmaceuticals, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 10
- Value as reported
- US$324M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Vanguard FTSE All-World ex-US Index Fund | 3.24M | US$269M | 83.2% |
| iShares MSCI India ETF | 370K | US$17.3M | 5.3% |
| ORIC Pharmaceuticals, Inc. | 989K | US$13.3M | 4.1% |
| Teamshares Inc. | 1.1M | US$7.99M | 2.5% |
| Foghorn Therapeutics Inc. | 1.57M | US$5.62M | 1.7% |
| PMV Pharmaceuticals, Inc. | 2.63M | US$4.39M | 1.4% |
| Surrozen, Inc. | 87,696 | US$2.82M | 0.87% |
| Alector, Inc. | 1.31M | US$2.42M | 0.75% |
| Tenaya Therapeutics, Inc. | 1.02M | US$613K | 0.19% |
| Merlin, Inc. | 47,610 | US$89,507 | 0.03% |
Source
Download original · View original at SEC